🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the efficacy and long-term safety...
Status
Completed
Location
Multiple Locations
Start Date
2007-10
Trial ID
NCT00566982
Treatments Being Tested
Vulvovaginal atrophy (VVA) is a condition that impacts up to 60% of the gro...
Status
Terminated
Location
Emory Midtown Hospital
Start Date
2017-06-30
Trial ID
NCT03018106
Treatments Being Tested
The objective of the study was to assess the long-term safety of daily dose...
Status
Completed
Location
Multiple Locations
Start Date
2006-05-08
Trial ID
NCT01586364
Treatments Being Tested
The purpose of the study is to assess the efficacy, safety and tolerability...
Status
Completed
Location
Multiple Locations
Start Date
2007-08
Trial ID
NCT00630539
Treatments Being Tested
Subjects will be randomized in a ratio of 1:1 to receive either 60 mg of os...
Status
Withdrawn
Location
Multiple Locations
Start Date
2014-01
Trial ID
NCT02010580
Ospemifene is the first oral and non-hormonal treatment for moderate or sev...
Status
Completed
Location
Hospital Clínic de Barcelona
Start Date
2021-11-01
Trial ID
NCT04677491
Treatments Being Tested
The purpose of this study is to determine whether ospemifene is more effect...
Status
Completed
Location
Multiple Locations
Start Date
2006-01
Trial ID
NCT00276094
Treatments Being Tested
This is an unblinded study to be conducted at a single research center, San...
Status
Completed
Location
San Diego Sexual Medicine
Start Date
2015-07
Trial ID
NCT02784613
Treatments Being Tested
The purpose of this study is to determine the safety and efficacy of ospemi...
Status
Completed
Location
Multiple Locations
Start Date
2008-07
Trial ID
NCT00729469
Treatments Being Tested
The objective of this study is to evaluate the efficacy and safety of ospem...
Status
Completed
Location
Multiple Locations
Start Date
2016-01-26
Trial ID
NCT02638337
Treatments Being Tested